Titre:
  • Pregnancy occurring during or following adjuvant trastuzumab in patients enrolled in the HERA trial (BIG 01-01).
Auteur:Abdel Azim, Hatem Hamdy; Metzger-Filho, Otto; Azambuja, Evandro; Loibl, Sibylle; Focant, Florine; Gresko, Ekaterina; Arfi, Mounir; Piccart-Gebhart, Martine
Informations sur la publication:Breast cancer research and treatment, 133, 1, page (387-391)
Statut de publication:Publié, 2012-05
Sujet CREF:Cancérologie
Mots-clés:Breast cancer
Counseling
Fetal outcome
Pregnancy
Trastuzumab
MeSH keywords:Abnormalities, Drug-Induced -- etiology
Abortion, Spontaneous -- chemically induced
Adult
Antibodies, Monoclonal, Humanized -- adverse effects -- therapeutic use
Antineoplastic Agents -- adverse effects -- therapeutic use
Breast Neoplasms -- drug therapy
Chemotherapy, Adjuvant
Clinical Trials, Phase III as Topic
Female
Humans
Pregnancy
Pregnancy Complications, Neoplastic -- drug therapy
Randomized Controlled Trials as Topic
Note générale:Journal Article
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0167-6806
info:doi/10.1007/s10549-012-1996-6
info:scp/84860330520
info:pmid/22367645